Found: 6
Select item for more details and to access through your institution.
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40315-9
- By:
- Publication type:
- Article
Accumulation of copy number alterations and clinical progression across advanced prostate cancer.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-022-01080-4
- By:
- Publication type:
- Article
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Plasma AR and abiraterone-resistant prostate cancer.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 312, p. 1, doi. 10.1126/scitranslmed.aac9511
- By:
- Publication type:
- Article
Genome-wide plasma DNA methylation features of metastatic prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF SELECT consortium assay.
- Published in:
- NAR Cancer, 2022, v. 4, n. 2, p. 1, doi. 10.1093/narcan/zcac016
- By:
- Publication type:
- Article